Intended for U.S. healthcare professionals only.
For corporate information, please visit Mallinckrodt.com.

Controlled Substances
In This Section

CONTROLLED SUBSTANCES

Controlled SubstancesMallinckrodt Pharmaceuticals produces the world's most diverse line of bulk medicinal controlled substances and is a world market leader. Our controlled substance product line includes natural opiates such as morphine sulfate and codeine phosphate.

Mallinckrodt offers semi-synthetic controlled substances such as hydrocodone, hydromorphone, and oxycodone obtained by chemical synthesis from natural opiates which are used to treat higher levels of pain than natural opiates. In addition, opioid antagonist products such as naloxone and naltrexone are available.

Synthetic-based products include methylphenidate and fentanyl, a strong synthetic controlled substance used to relieve moderate to severe pain, methadone for heroin (opiate) addiction and methylphenidate to treat Attention Deficit/Hyperactivity Disorder (ADHD).

In addition, Mallinckrodt is the world’s largest producer of noscapine products which is primarily used in the cough/cold market internationally.

Controlled Substances Product List

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2021 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc,(in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.

UnitedHealthcare creates and publishes the Machine-Readable Files on behalf of Mallinckrodt. To link to the Machine-Readable Files, please click on the URL provided: transparency-in-coverage.uhc.com.

Resources